Providence Regional Cancer Partnership Providence Reg. Cancer (2) is a clinical research site located in Everett, Washington, United States 98201.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Providence Regional Cancer Partnership Providence Reg. Cancer (2) has participated in 1 clinical trials.
Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Everett
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Providence Regional Cancer Partnership Providence Reg. Cancer (2) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Providence Regional Cancer Partnership Providence Reg. Cancer (2) has 1 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib.
Providence Regional Cancer Partnership Providence Reg. Cancer (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.